Mumbai, April 24 -- Revenue from operations declined 22.26% YoY to Rs 119.53 crore in the quarter ended 31 March 2025.

Loss before tax stood at Rs 15.66 crore in Q4 FY25, widening from a loss of Rs 0.93 crore in the same period last year.

EBITDA came in at Rs 6.32 crore in Q4 FY25, down 57.18% from Rs 14.76 crore reported in Q4 FY24.

Total expense tanked 13.23% year on year to Rs 135.98 crore during the quarter. The cost of materials consumed was Rs 85.45 crore (up 3.58% YoY), while employee benefits expense stood at Rs 14.43 crore (down 1.77% YoY) during the period under review.

On the margins front, operating margin narrowed to 4.62% in Q4 FY25, compared to 8.27% in Q4 FY24.

N. B. Godrej, chairman of Astec LifeSciences, said, "In Q...